Trade Financial News

Kaynes Technology India jumped as much as 9% on Wednesday, reaching Rs 5,085.25 on the BSE, after Jefferies upgraded the stock to ‘Buy’ from ‘Hold’. This upgrade came despite the brokerage slashing its target price to Rs 5,400, implying a potential upside of 6% from current levels. Jefferies’ upgrade follows a sharp 28% correction in the stock over the past month, which the brokerage views as overdone. Jefferies noted that Kaynes Technology remains the most backward-integrated Indian Electronics Manufacturing Services (EMS) player, providing it with a competitive edge in the industry. The company’s core manufacturing operating margin stands at 14-15%, significantly higher than its peers.

Exide Industries rose more than 5% to Rs 361.3 in Wednesday's trade on the BSE, despite a 22% decline in consolidated net profit to Rs 158 crore for Q3 FY25, compared to Rs 203 crore in the same period last year. Revenue from operations rose to Rs 4,017 crore in the third quarter, up from Rs 3,980 crore in the year-ago period.

Laurus Labs Ltd.(up 4.73 per cent), Glenmark Pharmaceuticals Ltd.(up 2.98 per cent), Ajanta Pharma Ltd.(up 2.82 per cent), Biocon Ltd.(up 2.77 per cent) and Granules India Ltd.(up 2.64 per cent) were among the top gainers.

HDFC Securities has a reduce call on Indian Oil Corporation with a target price of Rs 124. The current market price of Indian Oil Corporation is Rs 122.25. Indian Oil, incorporated in 1959, is a Large Cap company with a market cap of Rs 173550.02 crore, operating in the Gas & Petroleum sector. Indian Oil Corporation's key products/revenue segments include Petroleum Refinery Products, Other Operating Revenue, Scrap, Sale of services and Subsidy for the year ending 31-Mar-2024.

Indian market is likely to trade higher on Wednesday, tracking positive global cues. The Nifty futures closed positively with gains of 0.63%, reaching 22,990 levels on Tuesday. India VIX closed at 18.20 in the previous trading session.

ITC shareholders, shares of ITC Hotels would list on stock exchanges on Wednesday morning with brokerages expecting that the new stock could list between Rs 140-175 per share. «Comparable peers, Indian Hotels and EIH Ltd are currently trading at an FY26E EV/EBITDA multiple of 31.0x and 21.2x, respectively. Using an FY26E EBITDA estimate of Rs 1,458 crore, we anticipate ITCHL's listing to occur at an EV/EBITDA multiple of 20.0x-25.0x, implying a market capitalization range of Rs 29,163 crore to 36,454 crore. This would result in a potential listing price in the range of Rs 140-175 per share,» Deven Choksey said.

Sensex and Nifty 50, opened higher for the second consecutive session on Wednesday, led by IT and financial stocks, ahead of the U.S. Federal Reserve's rate decision later in the day and the Union Budget this weekend. As of 9:18 am, the BSE Sensex was up by 295 points, or 0.39%, at 76,182, while the Nifty 50 gained 77 points, or 0.33%, trading at 23,034.

Stocks that were in focus include names like Bajaj Auto, which rose 0.3% and Tata Motors, which gained 3% and Maruti, whose shares increased 0.9% on Tuesday.

earnings season is underway and about 94 companies will announce their results on Tuesday. Key results to watch out include from Bajaj Finance, Maruti, Tata Motors, Adani Power and Ambuja Cements. Apart from the above, companies like Blue Dart, CAMS, CarTrade Tech, Fino Payments Bank, Gujarat Fluorochemicals, Indian Bank, KPIT Technologies, Olectra Greentech, Quess Corp and a few others will also declare their quarter results.

Dr Agarwal's Healthcare IPO opened for subscription earlier today. The issue, which has a high OFS component worth Rs 2,727 crore out of the total offering of Rs 3,027 crore, will be available for investors to bid till January 31.

DeepSeek, an AI startup that has startled markets with its capacity to compete with industry leaders like OpenAI, kept a low profile as he built up a hedge fund and then refined its quantitative models to branch into artificial intelligence.

GMR Airports Ltd (GAL) reported a net profit of Rs 202.1 crore for the October-December quarter of FY25, reversing the Rs 486.4 crore loss recorded in the same period last year. This recovery was driven by growth in passenger traffic at major airports, including Delhi, Hyderabad, and Mopa in Goa, as well as improved operational performance. Revenue from operations increased by 19.2% to Rs 2,653.2 crore, compared to Rs 2,226.7 crore in Q3 FY24. The increase was primarily due to higher passenger traffic and tariff adjustments, with expenses rising slightly to Rs 1,661.5 crore from Rs 1,558.1 crore due to ongoing expansion projects.

«We maintain our sell on rise stance for the index and emphasize the importance of robust risk management, particularly in broader market segments like midcaps and small caps, while awaiting clearer signals,» said Ajit Mishra – SVP, Research, Religare Broking.

Bajaj Finance, Maruti, Tata Motors, SBI Card, Suzlon Energy among others will be in focus due to various news developments and third quarter results. Bajaj Finance, Maruti, Tata Motors, Adani Power and Ambuja Cements Shares of Bajaj Finance, Maruti, Tata Motors, Adani Power and Ambuja Cements will be in focus as the companies will announce their third quarter results today.

Federal Reserve’s rate decision and US mega-cap earnings. Japanese and Australian shares rose. Most other major markets in the region are closed for Lunar New Year holidays. US equity futures declined after the S&P 500 rose 0.9% and Nasdaq 100 advanced 1.6% on Tuesday, as Nvidia Corp. rallied 8.9% following the largest one-day value loss in history. The dollar and oil gained after President Donald Trump talked about across-the-board tariffs.

Subscribe to enjoy similar stories. India needs sustained long-term growth to pull people out of poverty, create jobs for the young, and boost incomes to widen the consumption base. I have long considered India’s potential real GDP growth rate to be 6% to 6.5% (6.2% is the average since 1980).

dollar index strengthened after comments about trade tariffs from US President Donald Trump. Intervention by the Reserve Bank of India helped contain excess losses, traders said The dollar index strengthened to 107.87 on Tuesday, after it had fallen to 106.96 the previous day, hurt by the selloff in US technology stocks.

Sebi) late Tuesday returned a letter by US-based Digvijay Laxmansinh Gaekwad, that had sought the regulator's permission to make a counteroffer to buy a stake in Religare Enterprises. Separately, two independent directors of Religare Enterprises questioned the company's decision to publish the letter written by Gaekwad to the capital markets regulator without verifying the sender's identity or signature, sources told ET.

FPIs have offloaded nearly Rs 2.18 lakh crore worth of Indian equities during this period. Several sectoral indices on the NSE, including auto, metals, oil & gas, energy, realty, media, and PSU banks, have plummeted more than 20% from their 52-week highs.

Trump’s namesake memecoin has likely generated at least $11.4 million in fees for entities linked to the president since its launch just before his second inauguration, according to an analysis by the crypto risk modeling firm Gauntlet. The crypto world was caught by surprise when the “official” Trump memecoin was released late on Jan. 17 by the former crypto skeptic turned supporter. The ensuing exuberance swelled the market value of the token to more than $14 billion, spurring speculation that it could potentially earn billions for Trump, while also raising concern about conflicts of interest.

initial public offering of ₹3,027 crore comprising an offer for sale of ₹2,727 crore with the rest being a fresh issue that dilutes the promoter shareholding from 37.7% to 32.5%. Of the issue proceeds, ₹195 crore will be used to repay borrowings. Business: Incorporated in 2010, Chennai-based DAHC is India's largest eye care service chain run by fourth-generation ophthalmologists. It has the highest number of eye care facilities in the country at 193, and 16 in Africa which contributes around 10% of the total revenues. At the end of September 2024, the company had 737 doctors and earned 66% of its revenues from surgeries, 13% from diagnosis and non-surgical treatments and 21% through the sale of eye care-related products, opticals, contact lenses and accessories.